Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

886 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adoptive B-cell transfer mouse model of human myeloma.
Tompkins VS, Rosean TR, Holman CJ, DeHoedt C, Olivier AK, Duncan KM, Jing X, Foor SD, Acevedo MR, Walsh SA, Tricot G, Zhan F, Janz S. Tompkins VS, et al. Among authors: zhan f. Leukemia. 2016 Apr;30(4):962-6. doi: 10.1038/leu.2015.197. Epub 2015 Jul 23. Leukemia. 2016. PMID: 26202932 Free PMC article. No abstract available.
FOXM1 is a therapeutic target for high-risk multiple myeloma.
Gu C, Yang Y, Sompallae R, Xu H, Tompkins VS, Holman C, Hose D, Goldschmidt H, Tricot G, Zhan F, Janz S. Gu C, et al. Among authors: zhan f. Leukemia. 2016 Apr;30(4):873-82. doi: 10.1038/leu.2015.334. Epub 2015 Dec 9. Leukemia. 2016. PMID: 26648534 Free PMC article.
The role of cytogenetics in myeloma.
Zhan F, Sawyer J, Tricot G. Zhan F, et al. Leukemia. 2006 Sep;20(9):1484-6. doi: 10.1038/sj.leu.2404330. Leukemia. 2006. PMID: 16926848 No abstract available.
(18)F-FDG-PET/CT imaging in an IL-6- and MYC-driven mouse model of human multiple myeloma affords objective evaluation of plasma cell tumor progression and therapeutic response to the proteasome inhibitor ixazomib.
Duncan K, Rosean TR, Tompkins VS, Olivier A, Sompallae R, Zhan F, Tricot G, Acevedo MR, Ponto LL, Walsh SA, Tygrett LT, Berger AJ, Waldschmidt T, Morse HC 3rd, Sunderland JJ, Janz S. Duncan K, et al. Among authors: zhan f. Blood Cancer J. 2013 Nov 29;3(11):e165. doi: 10.1038/bcj.2013.61. Blood Cancer J. 2013. PMID: 24292417 Free PMC article.
FOXM1 regulates glycolysis and energy production in multiple myeloma.
Cheng Y, Sun F, Thornton K, Jing X, Dong J, Yun G, Pisano M, Zhan F, Kim SH, Katzenellenbogen JA, Katzenellenbogen BS, Hari P, Janz S. Cheng Y, et al. Among authors: zhan f. Oncogene. 2022 Aug;41(32):3899-3911. doi: 10.1038/s41388-022-02398-4. Epub 2022 Jul 6. Oncogene. 2022. PMID: 35794249 Free PMC article.
CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications.
Tai YT, Landesman Y, Acharya C, Calle Y, Zhong MY, Cea M, Tannenbaum D, Cagnetta A, Reagan M, Munshi AA, Senapedis W, Saint-Martin JR, Kashyap T, Shacham S, Kauffman M, Gu Y, Wu L, Ghobrial I, Zhan F, Kung AL, Schey SA, Richardson P, Munshi NC, Anderson KC. Tai YT, et al. Among authors: zhan f. Leukemia. 2014 Jan;28(1):155-65. doi: 10.1038/leu.2013.115. Epub 2013 Apr 16. Leukemia. 2014. PMID: 23588715 Free PMC article.
886 results